Search research articles
Contact Us
Filters
Showing results (171-180 of 217) with videos related to
Page
of 22
Sort By:
Journal of Personalized Medicine
|
November 4, 2015
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic
John P Parisot, Heather Thorne, Andrew Fellowes, et al.
Clinical Sarcoma Research
|
September 22, 2016
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
Czar Louie Gaston, Robert J Grimer, Michael Parry, et al.
Cancer Treatment Reviews
|
September 3, 2025
Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action
Winette T A van der Graaf, Nina S Heiss, Carolyn L Hynes, et al.
Future Oncology (London, England)
|
September 28, 2023
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue
Antony J Mersiades, Benjamin J Solomon, David M Thomas, et al.
The Journal of Clinical Investigation
|
November 16, 2013
Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation
Maya Kansara, Huei San Leong, Dan Mei Lin, et al.
Hereditary Cancer in Clinical Practice
|
March 27, 2026
Challenging interpretation of low-level PTCH1 mosaicism in patients with clinically diagnosed Gorlin syndrome: a case series and review of the literature
Tanya M Dwarte, Rozanna Alli, Shweta Srinivasa, et al.
BMJ Open
|
February 10, 2025
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma
Kristen McParland, Eng-Siew Koh, Benjamin Kong, et al.
Nature Communications
|
February 10, 2026
A catalogue of early diverged contemporary human genome variation reveals distinct Khoe-San populations
Weerachai Jaratlerdsiri, Pamela X Y Soh, Tingting Gong, et al.
NPJ Precision Oncology
|
September 9, 2024
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation
Subotheni Thavaneswaran, Frank Lin, John P Grady, et al.
Journal of Adolescent and Young Adult Oncology
|
January 27, 2016
Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor Biology
David M Thomas, Miriam Wilhelm, Anne-Marie Cleton-Jansen, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 217) with videos related to
Sort By:
Page
of 22
Journal of Personalized Medicine
|
November 4, 2015
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic
John P Parisot, Heather Thorne, Andrew Fellowes, et al.
Clinical Sarcoma Research
|
September 22, 2016
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
Czar Louie Gaston, Robert J Grimer, Michael Parry, et al.
Cancer Treatment Reviews
|
September 3, 2025
Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action
Winette T A van der Graaf, Nina S Heiss, Carolyn L Hynes, et al.
Future Oncology (London, England)
|
September 28, 2023
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue
Antony J Mersiades, Benjamin J Solomon, David M Thomas, et al.
The Journal of Clinical Investigation
|
November 16, 2013
Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation
Maya Kansara, Huei San Leong, Dan Mei Lin, et al.
Hereditary Cancer in Clinical Practice
|
March 27, 2026
Challenging interpretation of low-level PTCH1 mosaicism in patients with clinically diagnosed Gorlin syndrome: a case series and review of the literature
Tanya M Dwarte, Rozanna Alli, Shweta Srinivasa, et al.
BMJ Open
|
February 10, 2025
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma
Kristen McParland, Eng-Siew Koh, Benjamin Kong, et al.
Nature Communications
|
February 10, 2026
A catalogue of early diverged contemporary human genome variation reveals distinct Khoe-San populations
Weerachai Jaratlerdsiri, Pamela X Y Soh, Tingting Gong, et al.
NPJ Precision Oncology
|
September 9, 2024
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation
Subotheni Thavaneswaran, Frank Lin, John P Grady, et al.
Journal of Adolescent and Young Adult Oncology
|
January 27, 2016
Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor Biology
David M Thomas, Miriam Wilhelm, Anne-Marie Cleton-Jansen, et al.
Page
of 22